Tom 12, Nr 6 (2017)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2017-12-29
Wyświetlenia strony
565
Wyświetlenia/pobrania artykułu
857
Elektroterapia, interwencje, leki… Migawki z Kongresu Europejskiego Towarzystwa Kardiologicznego w Barcelonie, 26–30 sierpnia 2017 roku
DOI: 10.5603/FC.2017.0118
Folia Cardiologica 2017;12(6):625-628.
Streszczenie
Brak
Referencje
- Escaned J, Collet C, Ryan N, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J. 2017; 38(42): 3124–3134.
- Marrouche NF, Brachmann J, on behalf of CASTLE-AF Investigators. Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: The CASTLE-AF trial. European Society of Cardiology 2017 Congress. August 27, 2017, Barcelona, Spain.
- Ezekowitz MD, Pollack CV, Sanders P, et al. Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial. Am Heart J. 2016; 179: 59–68.
- Cannon CP, Bhatt DL, Oldgren J, et al. RE-DUAL PCI Steering Committee and Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017; 377(16): 1513–1524.
- Townsend RR, Mahfoud F, Kandzari D, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017; 390(10108): 2160–2170.
